PMA P050047S106

Device
Juvéderm Ultra XC; Juvéderm Ultra Plus XC
Applicant
Allergan
PMA number
P050047
Supplement
S106
Product code
LMH
Decision date
2026-11-04
Classification
General, Plastic Surgery
Generic name
Implant, dermal, for aesthetic use
Approval order statement
approval for the use of an additional supplier of High Molecular Weight (HMW) Sodium Hyaluronate (NaHA) as a raw material in the manufacture of Juvéderm formulations.

Current openFDA PMA Record#

Device
Juvéderm Ultra XC; Juvéderm Ultra Plus XC
Applicant
Allergan
PMA number
P050047
Supplement
S106
Product code
LMH
Generic name
Implant, dermal, for aesthetic use
Decision date
2026-11-04
Decision code
APPR
Date received
2025-09-04
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Approval order statement
approval for the use of an additional supplier of High Molecular Weight (HMW) Sodium Hyaluronate (NaHA) as a raw material in the manufacture of Juvéderm formulations.